Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

People with HIV and low T cell counts have more hair and scalp problems.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

A woman developed a severe skin reaction after getting a birth control implant.

Early diagnosis and treatment of TPP can prevent complications.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.